BioCentury

7:00 AM GMT, May 8, 2006
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Finance

EPS watch

EPS watch

EPS watch
PDL (PDLI) and ViroPharma (VPHM) both had big declines after reporting first quarter numbers that were worse than expected. On the upside, Myriad (MYGN) jumped 11% after posting strong sales growth for its predictive medicine products. (A) Results for 2Q ended March 31; (B) Results for 3Q ended March 31; Mcap in $M
Company 1Q06 EPS est 1Q06 EPS actual Outcome Growth from 1Q05 5/5 cls Wk chg % chg Mcap chg 5/5

Read the full 771 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.